Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lucidi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Neuropsychiatry|September 14, 2022
Psychological Distress in Healthcare Workers During the Covid-19 Pandemic: Development and Validation of the Italian Version of the Healthcare Workers Emergency Distress Questionnaire (HEDQ)Sara Lucidi, Sara Iannattone, Fabio Mallardo, et al.
La Radiologia Medica|June 3, 2021
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patientsBeatrice Detti, Silvia Scoccianti, Maria Ausilia Teriaca, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case reportPierluigi Bonomo, Sara Lucidi, Isacco Desideri, et al.
Cancer Treatment and Research Communications|December 18, 2020
Regorafenib in glioblastoma recurrence: A case reportBeatrice Detti, Silvia Scoccianti, Sara Lucidi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2024
Dose constraints in breast cancer radiotherapy. A critical reviewFiorenza De Rose, Maria Carmen De Santis, Sara Lucidi, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Fiorenza De Rose, Riccardo Ray Colciago, Sara Lucidi, et al.
La Radiologia Medica|August 11, 2022
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literatureBeatrice Detti, Silvia Scoccianti, Virginia Maragna, et al.
Medical Oncology (Northwood, London, England)|June 6, 2022
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)Isacco Desideri, Sara Lucidi, Giulio Francolini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 3, 2026
Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in ItalyFiorenza De Rose, Sara Lucidi, Elisabetta Bonzano, et al.
Frontiers in Oncology|April 7, 2023
Choline PET/CT in recurrent prostate cancerBeatrice Detti, Maria Grazia Carnevale, Sara Lucidi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Neuropsychiatry|September 14, 2022
Psychological Distress in Healthcare Workers During the Covid-19 Pandemic: Development and Validation of the Italian Version of the Healthcare Workers Emergency Distress Questionnaire (HEDQ)Sara Lucidi, Sara Iannattone, Fabio Mallardo, et al.
La Radiologia Medica|June 3, 2021
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patientsBeatrice Detti, Silvia Scoccianti, Maria Ausilia Teriaca, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case reportPierluigi Bonomo, Sara Lucidi, Isacco Desideri, et al.
Cancer Treatment and Research Communications|December 18, 2020
Regorafenib in glioblastoma recurrence: A case reportBeatrice Detti, Silvia Scoccianti, Sara Lucidi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2024
Dose constraints in breast cancer radiotherapy. A critical reviewFiorenza De Rose, Maria Carmen De Santis, Sara Lucidi, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Fiorenza De Rose, Riccardo Ray Colciago, Sara Lucidi, et al.
La Radiologia Medica|August 11, 2022
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literatureBeatrice Detti, Silvia Scoccianti, Virginia Maragna, et al.
Medical Oncology (Northwood, London, England)|June 6, 2022
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)Isacco Desideri, Sara Lucidi, Giulio Francolini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 3, 2026
Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in ItalyFiorenza De Rose, Sara Lucidi, Elisabetta Bonzano, et al.
Frontiers in Oncology|April 7, 2023
Choline PET/CT in recurrent prostate cancerBeatrice Detti, Maria Grazia Carnevale, Sara Lucidi, et al.
Pageof 2